SCIENTURE HOLDINGS, INC. Professional Fees
SCIENTURE HOLDINGS, INC. (SCNX) reported Professional Fees of $963.75 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. professional fees for the quarter ending 2026-06-30 was $963.75K, a 359.45% increase year-over-year.
- SCIENTURE HOLDINGS, INC. professional fees for the quarter ending 2026-03-31 was $932.55K, a 125.88% increase year-over-year.
- SCIENTURE HOLDINGS, INC. professional fees for the quarter ending 2025-12-31 was $464.36K, a 163.43% increase year-over-year.
- SCIENTURE HOLDINGS, INC. professional fees for the quarter ending 2025-09-30 was $1.32M, a 122.60% increase year-over-year.
- SCIENTURE HOLDINGS, INC. professional fees for fiscal 2025 was $2.41M, a 65.11% increase from fiscal 2024.
- SCIENTURE HOLDINGS, INC. professional fees for fiscal 2024 was $1.46M, a 66.64% increase from fiscal 2023.
- SCIENTURE HOLDINGS, INC. professional fees for fiscal 2023 was $875.14K, a 87.50% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. professional fees for fiscal 2022 was $466.74K, a 57.37% decline from fiscal 2021.
| Period end | Professional Fees 3 month | Professional Fees 3 month as first filed | Professional Fees 6 month | Professional Fees 6 month as first filed | Professional Fees 9 month | Professional Fees 9 month as first filed | Professional Fees 12 month | Professional Fees 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $963.75K 10-Q · filed 2026-08-13 | $1.90M 10-Q · filed 2026-08-13 | $2.36M derived: sum of 3 quarters · filed 2026-08-13 | $3.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $932.55K 10-Q · filed 2026-05-15 | $1.40M derived: sum of 2 quarters · filed 2026-05-15 | $2.72M derived: sum of 3 quarters · filed 2026-05-15 | $2.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $464.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.79M derived: sum of 2 quarters · filed 2026-03-30 | $1.99M derived: sum of 3 quarters · filed 2026-08-13 | $2.41M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $1.32M 10-Q · filed 2025-11-12 | $1.53M derived: sum of 2 quarters · filed 2026-08-13 | $1.94M 10-Q · filed 2025-11-12 | $2.12M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $209.76K 10-Q · filed 2026-08-13 | $622.61K 10-Q · filed 2026-08-13 | $798.89K derived: sum of 3 quarters · filed 2026-08-13 | $1.39M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $412.85K 10-Q · filed 2026-05-15 | $589.13K derived: sum of 2 quarters · filed 2026-05-15 | $1.18M derived: sum of 3 quarters · filed 2026-05-15 | $1.69M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $176.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $769.64K derived: sum of 2 quarters · filed 2026-03-30 | $1.28M derived: sum of 3 quarters · filed 2026-03-30 | $1.46M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $593.36K 10-Q · filed 2025-11-12 | $1.10M derived: sum of 2 quarters · filed 2025-11-12 | $1.28M 10-Q · filed 2025-11-12 | $1.54M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $509.14K 10-Q · filed 2025-08-12 | $688.69K 10-Q · filed 2025-08-12 | $944.03K derived: sum of 3 quarters · filed 2025-08-12 | $1.24M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $179.55K 10-Q · filed 2025-05-12 | $434.89K derived: sum of 2 quarters · filed 2025-05-12 | $730.39K derived: sum of 3 quarters · filed 2025-05-12 | $918.74K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $255.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $550.84K derived: sum of 2 quarters · filed 2025-03-26 | $739.18K derived: sum of 3 quarters · filed 2025-03-26 | $875.14K 10-K · filed 2025-03-26 | $1.47M 10-K · filed 2024-04-22 | |||
| 2023-09-30 | $295.50K 10-Q · filed 2024-11-06 | $418.29K 10-Q · filed 2024-01-16 | $483.84K derived: sum of 2 quarters · filed 2024-11-06 | $619.79K 10-Q · filed 2024-11-06 | $782.29K 10-Q · filed 2024-01-16 | $829.72K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $188.34K 10-Q · filed 2024-08-09 | $229.62K 10-Q · filed 2023-08-18 | $324.30K 10-Q · filed 2024-08-09 | $369.29K 10-Q · filed 2023-08-18 | $534.23K derived: sum of 3 quarters · filed 2024-08-09 | $616.93K derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $135.95K 10-Q · filed 2024-06-26 | $139.66K 10-Q · filed 2023-05-15 | $345.88K derived: sum of 2 quarters · filed 2024-06-26 | $428.59K derived: sum of 3 quarters · filed 2024-06-26 | $539.65K derived: sum of 4 quarters · filed 2024-06-26 | |||
| 2022-12-31 | $209.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $292.64K derived: sum of 2 quarters · filed 2024-04-22 | $403.69K derived: sum of 3 quarters · filed 2024-04-22 | $466.74K 10-K · filed 2024-04-22 | $519.64K 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $82.71K 10-Q · filed 2024-01-16 | $95.28K 10-Q · filed 2022-11-07 | $193.77K derived: sum of 2 quarters · filed 2024-01-16 | $256.81K 10-Q · filed 2024-01-16 | $307.34K 10-Q · filed 2022-11-07 | $632.43K derived: sum of 4 quarters · filed 2024-01-16 | ||
| 2022-06-30 | $111.06K 10-Q · filed 2023-08-18 | $212.07K 10-Q · filed 2023-08-18 | $549.72K derived: sum of 3 quarters · filed 2023-08-18 | $755.18K derived: sum of 4 quarters · filed 2023-08-18 | ||||
| 2022-03-31 | $101.01K 10-Q · filed 2023-05-15 | $438.66K derived: sum of 2 quarters · filed 2023-05-15 | $644.12K derived: sum of 3 quarters · filed 2023-05-15 | $931.11K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $337.65K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $543.11K derived: sum of 2 quarters · filed 2023-03-27 | $830.10K derived: sum of 3 quarters · filed 2023-03-27 | $1.09M 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $205.46K 10-Q · filed 2022-11-07 | $492.44K derived: sum of 2 quarters · filed 2022-11-07 | $757.26K 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | $286.99K 10-Q · filed 2022-07-25 | $551.81K 10-Q · filed 2022-07-25 | ||||||
| 2021-03-31 | $264.82K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |